Article
Clinical, biological, electrophysiological and therapeutic profile of patients with anti-MAG neuropathy according to MYD88L265P and CXCR4 mutations and underlying haemopathy.
Journal of neurology - 1 Mar 2024
Guérémy Alexandre, Boucraut José, Boudjarane John, Grapperon Aude-Marie, Fortanier Etienne, Farnault Laure, Gabert Jean, Vely Frédéric, Lacroix Romaric, Kouton Ludivine, Attarian Shahram, Delmont Emilien
Abstract excerpt
INTRODUCTION: Anti-MAG neuropathies are associated with an IgM monoclonal gammopathy of undetermined significance (MGUS) or with a malignant haemopathy. Our objective was to determine whether the presence of a haemopathy or somatic mutations of MYD88 and CXCR4 genes influences disease presentation and response to rituximab (RTX). METHODS: We included 79 patients (mean age 74 years, disease duration 9.68 years)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
